FULCFulcrum Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 15735
Ticker: FULC
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2019-07-18
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: FULC

Detail

Enriched 2026-08-14 20:47

Market cap: $283,825,796.04
Shares outstanding (class): 76,297,257
Shares outstanding (weighted): 76,297,257
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 55
Location: CAMBRIDGE, MA
Homepage: https://www.fulcrumtx.com
Description: Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

Market cap and share counts drift.

Funds holding this security

79 funds · 81 positions · $67.32M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$15.91M	0.00%	2,074,332 NS	FIGI
abrdn Life Sciences Investors —	—	$11.65M	2.08%	1,518,506 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$11.04M	0.02%	1,439,480 NS	FIGI
abrdn Healthcare Investors —	—	$5.32M	0.47%	693,447 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$4.21M	0.01%	548,767 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$3.60M	0.03%	468,836 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$3.29M	0.04%	429,371 NS	FIGI
State Street(R) SPDR(R) S&P(R) Pharmaceuticals … SPDR SERIES TRUST	XPH	$2.82M	0.92%	367,717 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$1.16M	0.10%	150,844 NS	FIGI
Simplify Health Care ETF Simplify Exchange Traded Funds	PINK	$899.3K	0.38%	117,254 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$746.0K	0.02%	97,264 NS	FIGI
Fidelity Small Cap Value Index Fund Fidelity Salem Street Trust	—	$525.0K	0.03%	68,442 NS	FIGI
EQ/2000 Managed Volatility Portfolio EQ Advisors Trust	—	$470.1K	0.01%	61,286 NS	FIGI
Fidelity Enhanced Small Cap ETF Fidelity Covington Trust	FESM	$415.3K	0.01%	54,151 NS	FIGI
BlackRock Advantage Small Cap Growth Fund BlackRock Funds	—	$354.6K	0.05%	46,226 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERFULC
FIGI_COMPOSITEBBG00DDY1RK9
FIGI_SHARE_CLASSBBG00DDY1RM7
CIK0001680581
ISINUS3596161097
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Fulcrum Therapeutics is a biopharmaceutical company developing small molecule medicines, classified under pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.